Reckitt Benckiser Group PLC

Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Johann A. Benckiser in 1823 and is headquartered in Slough, the United Kingdom.

Reckitt Benckiser Group plc (OTCPK:RBGPF) Q3 2024 Results Conference Call October 23, 2024 3:30 AM ET Company Participants Nick Ashworth - Head of Investor Relations Kris Licht - Chief Executive Officer Shannon Eisenhardt - CFO & Executive Director Conference Call Participants Rashad Kawan - Morgan Stanley Iain Simpson - Barclays Guillaume Delmas - UBS Jeremy Fialko - HSBC Celine Pannuti - JP Morgan David Hayes - Jefferies Victoria Petrova - Bank of America Jeff Stent - Exane BNP Paribas Tom Sykes - Deutsche Bank Nick Ashworth Good morning, and welcome to Reckitt's Q3 trading update. Our CEO, Kris Licht, and our CFO, Shannon Eisenhardt, will take you through some prepared remarks followed by Q&A.

Reckitt Benckiser Group plc (RBGPF) Q3 2024 Earnings Call Transcript

Clorox

Investors interested in Soap and Cleaning Materials stocks are likely familiar with Reckitt Benckiser Group PLC (RBGLY) and Clorox (CLX). But which of these two stocks offers value investors a better bang for their buck right now?

RBGLY or CLX: Which Is the Better Value Stock Right Now?

Shares in Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) rose almost 4% to a six-month high after the Cilit Bang, Nurofen and Durex maker reported a smaller fall in sales than investors feared. Third-quarter numbers showed group organic sales down 0.5%, beating the average City analyst forecast for a 1.7% decline.

Reckitt Benckiser results 'good enough' but not out of the woods yet

Lysol maker Reckitt Benckiser's revenue fell by less than expected in the third quarter as declines in sales volumes eased, and confirmed its targets for the full year.

Lysol Maker Reckitt Benckiser Beats Views as Easing Prices Draw Shoppers

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) has said sales fell over the third quarter as revenue from its nutrition wing slumped. Like for like revenue declined by 0.5% to £3,46 billion during the quarter, the consumer goods firm said, or by 4.0% on an international reporting standards basis.

Reckitt Benckiser posts drop in revenue as nutrition wing weighs

Reckitt reported a smaller than expected fall in third-quarter underlying sales on Wednesday, helped by its health business, which makes Nurofen painkillers and Strepsils lozenges.

Healthcare helps Reckitt beat quarterly sales estimates

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) will offer up third-quarter results next Wednesday, 23 October reflecting what analysts believe will have seen a drop in sales. Barclays analysts forecast organic sales growth to have fallen by 1.2% over the quarter as weaker prices offset volume growth.

Reckitt promotional push threatens sales as earnings loom

Investors looking for stocks in the Soap and Cleaning Materials sector might want to consider either Reckitt Benckiser Group PLC (RBGLY) or Clorox (CLX). But which of these two stocks is more attractive to value investors?

RBGLY vs. CLX: Which Stock Is the Better Value Option?

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) could return up to £12.5 billion to shareholders, about 40% of its market value, as part of a major strategic overhaul, according to Barclays. The company plans to shift from a category-first model to a geography-first approach, with asset sales playing a key role.

Reckitt Benckiser could return £12.5bn after overhaul, says leading investment bank

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) is facing multiple challenges ahead of its third-quarter results, with Jefferies forecasting a -1% drop in like-for-like sales. Key reasons for the limp forecast include weaker scanner data from the US and the impact of a tornado on the company's nutrition segment, which is expected to be heavily weighted in the third quarter.

Reckitt Benckiser has sales and legal risks aplenty as third-quarter results approach

Abbott Labs

A Missouri mother and her lawyers this week will aim to convince a jury that Abbott , Reckitt's Mead Johnson and St. Louis Children's Hospital are responsible for a severe intestinal illness that she says her premature son got from the companies' formulas after he was born at the hospital.

Abbott, Reckitt face trial over premature baby formula amid alarm from doctors

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) is in talks with interested parties to dispose of its £6 billion homecare portfolio, which includes household brands Air Wick, Mortein, Calgon and Cillit Bang, Bloomberg has reported. The reported discussions align with an announcement from the FTSE 100-listed FMCG giant in July that plans to get rid of certain non-core products from its portfolio.

Reckitt in talks to sell £6bn homecare portfolio, reports Bloomberg

Reckitt Benckiser has initiated early discussions with potential suitors for a sale of its homecare assets, which could be worth over 6 billion pounds ($7.89 billion), Bloomberg News reported on Tuesday.

Reckitt initiates discussions on $7.9 billion homecare assets sale, Bloomberg reports

Adobe

Allianz SE

Bank of Nova Scotia

Cigna

Canadian National Railway Company

Enterprise Products Partners

Siemens AG

UnitedHealth Group

The economy is stable but cooling, with the labor market showing signs of slowing down. GDP growth is likely to keep falling, and individual companies could suffer. Long-term investors should focus on companies with strong risk management and adaptability to changing economic conditions, ensuring consistent returns and dividend growth. These 10 companies average an A-credit rating and S&P risk management in the top 0.4% of global companies.

10 High-Yield A-Rated Blue-Chips For Potentially Scary Times Ahead

Haleon PLC

While the FTSE 100 continues to suffer its worst session in recent times, dropping 2.5%, there are a handful of companies which have been able to buck the bearish trend.  Out of London's blue chips, only Haleon and Reckitt have been able to lift into the green, up by 0.1% and 0.4% respectively.

Haleon, Reckitt, Wizz Air: Stocks lifting despite global sell-off

Shares of Abbott Laboratories and U.K.-listed Reckitt Benckiser both drop after a Missouri jury rules against the American healthcare company.

Abbott Labs Stock Falls After Baby-Formula Ruling. Reckitt Benckiser Tumbles Too.

U.K. consumer-products giant Reckitt saw its share price slump after a jury awarded $495 million in a key baby-formula case.

Baby-formula settlement drags Reckitt down after $495 million jury award against Abbott

Abbott Laboratories' shares fell nearly 7% premarket, while British peer Reckitt Benckiser slumped 9% on Monday, after the U.S. healthcare firm was ordered to pay $495 million in damages related to its formula for premature infants.

Abbott shares slide after trial verdict, weigh on rival Reckitt Benckiser

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) shares tumbled 7.5% on Monday morning after a litigation decision in the US against Abbott Laboratories (NYSE:ABT) on Friday, where investors are reading across to the potential impact on the FTSE-listed company.  Abbott was ordered to pay almost $500 million over allegations that it hid the risks around its premature infant formula feed, with the case alleging that the formula risks causing a potentially fatal bowel disease.

Reckitt Benckiser shares whacked by US infant formula litigation read-across

Reckitt Benckiser Group plc (OTCPK:RBGPF) Q2 2024 Results Conference Call July 24, 2024 3:30 AM ET Company Participants Richard Joyce - Head of Investor Relations Kristoffer Licht - CEO & Executive Director Shannon Eisenhardt - CFO & Executive Director Conference Call Participants Guillaume Delmas - UBS Chris Pitcher - Redbur Jeremy Fialko - HSBC James Edwardes Jones - RBC Iain Simpson - Barclays Fulvio Joh - Berenberg Thomas Sykes - Deutsche Bank Richard Joyce Good morning, everyone. Welcome to Reckitt's Half Year 2024 Results Presentation and our Strategic Update.

Reckitt Benckiser Group plc (RBGPF) Q2 2024 Earnings Call Transcript

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB)'s dramatic upheaval plans will result in the divestment of approximately 30% of its business, according to analysis from UBC. Announced alongside an interim trading update on Wednesday, the restructuring forms part of Reckitt's strategy to sharpen its brand portfolio and streamline its operations, focusing on higher-growth, high-margin Powerbrands.

Reckitt restructuring will see 30% of business divested - analyst

Reckitt Benckiser Group on Wednesday said it plans to refocus its business on its top-selling brands including Durex and Gaviscon by pulling away from its more troubled and less profitable segments in a bid to boost its dwindling share price by creating a “simpler, more effective firm.”

Reckitt to simplify by dropping home products and troubled infant-formula unit

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB), the FMCG giant responsible for the majority of the average Brit's cleaning cupboard, has declared a sweeping reorganisation of its business that will see it dispose of ‘non-core' brands. The FTSE 100-listed conglomerate plans to get rid of Air Wick, Mortein, Calgon, Cillit Bang and other non-core products from its home care range.

Job cuts expected as Reckitt declares major business shake-up

Reckitt Benckiser will consider options for its troubled nutrition business and offload a portfolio of homecare brands by the end of 2025, it said on Wednesday, planning to refocus on healthcare and hygiene.

Reckitt to offload homecare brands, consider nutrition options

Barclays

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) half-year update on Wednesday (24 July) will see infant formula litigation remain the dominant factor, analysts at Barclays believe. One of the investment problems is that the is little visibility on the timing of any resolution, says the bank.

News for Reckitt Benckiser Group PLC Stock (RBGLY)